Fracasso PM - Search Results

1

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.

Fracasso PM, Blum KA, Tan BR, Fears CL, Bartlett NL, Arquette MA, Clark RS. Fracasso PM, et al. Cancer. 2002 Nov 15;95(10):2223-9. doi: 10.1002/cncr.10937. Cancer. 2002. PMID: 12412177 Free article. Clinical Trial.

2

Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma.

Perez CA, Fields JN, Fracasso PM, Philpott G, Soares RL Jr, Taylor ME, Lockett MA, Rush C. Perez CA, et al. Among authors: fracasso pm. Cancer. 1994 Jul 1;74(1 Suppl):466-76. doi: 10.1002/cncr.2820741336. Cancer. 1994. PMID: 8004622

3

Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.

Fracasso PM, Tan BR Jr, Grieff M, Stephenson J Jr, Liapis H, Umbeck NL, Von Hoff DD, Rowinsky EK. Fracasso PM, et al. J Natl Cancer Inst. 1999 Oct 20;91(20):1779-80. doi: 10.1093/jnci/91.20.1779. J Natl Cancer Inst. 1999. PMID: 10528031 No abstract available.

4

Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies.

Fracasso PM, Westervelt P, Fears CL, Rosen DM, Zuhowski EG, Cazenave LA, Litchman M, Egorin MJ. Fracasso PM, et al. J Clin Oncol. 2000 Mar;18(5):1124-34. doi: 10.1200/JCO.2000.18.5.1124. J Clin Oncol. 2000. PMID: 10694566 Clinical Trial.

5

Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study.

Fracasso PM, Brady MF, Moore DH, Walker JL, Rose PG, Letvak L, Grogan TM, McGuire WP. Fracasso PM, et al. J Clin Oncol. 2001 Jun 15;19(12):2975-82. doi: 10.1200/JCO.2001.19.12.2975. J Clin Oncol. 2001. PMID: 11408492 Clinical Trial.

6

Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.

Fracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL. Fracasso PM, et al. Ann Oncol. 2002 Nov;13(11):1819-25. doi: 10.1093/annonc/mdf342. Ann Oncol. 2002. PMID: 12419757 Free article. Clinical Trial.

7

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Fracasso PM, Blessing JA, Wolf J, Rocereto TF, Berek JS, Waggoner S. Fracasso PM, et al. Gynecol Oncol. 2003 Jul;90(1):177-80. doi: 10.1016/s0090-8258(03)00253-1. Gynecol Oncol. 2003. PMID: 12821360 Clinical Trial.

8

Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.

Fracasso PM, Rodriguez LC, Herzog TJ, Fears CL, Goodner SA, Govindan R, Picus J, Rader JS, Tan BR, Arquette MA. Fracasso PM, et al. Cancer. 2003 Aug 1;98(3):610-7. doi: 10.1002/cncr.11547. Cancer. 2003. PMID: 12879480 Free article. Clinical Trial.

9

Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.

Fracasso PM, Blessing JA, Morgan MA, Sood AK, Hoffman JS. Fracasso PM, et al. J Clin Oncol. 2003 Aug 1;21(15):2856-9. doi: 10.1200/JCO.2003.03.077. J Clin Oncol. 2003. PMID: 12885801 Clinical Trial.

10

Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.

Fracasso PM, Goldstein LJ, de Alwis DP, Rader JS, Arquette MA, Goodner SA, Wright LP, Fears CL, Gazak RJ, Andre VA, Burgess MF, Slapak CA, Schellens JH. Fracasso PM, et al. Clin Cancer Res. 2004 Nov 1;10(21):7220-8. doi: 10.1158/1078-0432.CCR-04-0452. Clin Cancer Res. 2004. PMID: 15534095 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters